SUMMARY A study of 304 sexually active homosexual men, most of whom had multiple casual partners, showed that receptive anogenital intercourse, independent ofanal bleeding, was the only risk factor for HTLV-III/LAV transmission. There was no evidence that HTLV-III/LAV infection, measured by seropositivity, was transmitted by oroanal or orogenital routes, or that insertive penile intercourse constituted a risk. The strongest predictor of seropositivity proved to be homosexual activity for more than five years, which may lead to enhanced susceptibility to infection. Sexual exposure to European men seemed to be even more hazardous than sexual exposure to men from the United States of America, and emphasised the epidemiological importance of the promiscuous homosexual abroad. Skin complaints were the most common presenting symptoms in men with antibody to HTLV-III/LAV. Extrainguinal lymphadenopathy was the commonest sign, which was present in just under half of those who were seropositive. More than one quarter of seropositive patients had had sexual intercourse with a woman in the five years before being tested.
Introduction
Several studies have sought to relate the lifestyle and sexual practices of homosexual men to the development of the acquired immune deficiency syndrome (AIDS). The first studies concentrated on the sexual habits of men with Kaposi's sarcoma. ' 2 Later studies examined the habits ofmen with human T cell lymphotropic virus type HI or lympadenopathy associated virus (HTLV-III/LAV) infection as indicated by the presence of antibody.34 All these reports have come from the United States of America, mostly from New York. They have drawn patients and controls from diverse sources, and have reported on relatively small numbers. They have all found that AIDS and seropositivity are associated with having increased numbers of sexual partners and the practice of receptive anogenital intercourse. A report from Denmark investigated serum samples and lifestyle data of 250 homosexual men in 1981; 22 (8-8%) were seropositive, and this was associated with an increased incidence of receptive anal intercourse. 5 The study published here was a prospective one of a cohort of patients attending one outpatient clinic.
Patients and methods
We studied a group ofhomosexual men who attended a department of genitourinary medicine in West London during the six months from November 1984 to May 1985. Patients were assessed if they were willing to be tested for antibody to HTLV-III/LAV and to complete the study questionnaire. All the patients who entered the study underwent a physical examination and routine tests for sexually transmitted diseases (STDs); these findings were recorded before their anti-HTLV-IIIILAV status was known.
QUESTIONNAIRE
The same short study questionnaire was completed by all participants. They were asked to indicate the most appropriate of predetermined responses. Completion and comprehension were checked by one of us (ST). The questionnaire asked participants for estimates of the lifetime number of sexual partners and for the number of partners in the preceding 12 months. Multiplicity of sexual partners was strongly related to anti-HTLV-III/LAV seropositivity. Significantly greater risk was found in men who had had more than 20 lifetime partners (p=0 003 with Yates's correction) and also in men who had had more than 20 partners in the preceding year (p=0005). Of the men who had antibody to HTLV-III/LAV, 93% (91/98) had been homosexually active for more than five years, compared with 74% (153/206) of those who were seronegative (p=00001). There was a significant positive trend between these three variables and seropositivity. Indeed, seropositivity was more than three times greater in men who had been homosexually active for 6-10 years (40%) than in those who had been homosexually active for 1-5 years (12%) (figure). None ofthe seven patients with fewer than 10 sexual partners in his lifetime, and only one of the 18 with fewer than 20 partners, was seropositive. A higher proportion of seropositive men (5 5%) than seronegative men (46%) reported having a regular sexual partner. This was an unexpected finding, which has important epidemiological implications in terms of the effect of repeated exposure to HTLV-III/LAV. Also of concern, in view of the consequences of heterosexual transmission, was the reporting of intercourse with women by a third of the cohort (including 27% of those who were seropositive) within the previous five years.
Though the strong correlation of anti-HTLV-III/ LAV seropositivity with extrainguinal lymphadenopathy (p<00001) was anticipated, its association with common skin diseases in otherwise asymptomatic men is a new finding. Skin problems, including some atypical skin diseases, have been noted in homosexual men suffering from AIDS or persistent generalised lymphadenopathy (PGL).'0 Our findings indicate that skin disease may be a presenting as well as a late feature of HTLV-III/LAV infection.
Most ofthe common STDs had occurred more often in anti-HTLV-III/LAV seropositive men, probably because they had had significantly more partners. The absence of association with non-specific urethritis and chlamydial infection is not readily explained. A history of "glandular fever" did not appear more B A Evans, S G Dawson, K A McLean, et al commonly among the seropositive group, which suggests that this is not a common marker of acute HTLV-IIULAV infection.
Though the findings concerning hepatitis B infection were compatible with an oroanal route oftransmission, there is no evidence that this was the case in respect of HTLV-III/LAV infection. Taken with the lack of risk attached to swallowing semen, our findings support the view that HTLV-III/LAV does not infect by the oral route.
The typical anti-HTLV/III LAV seropositive Briton was a man in his thirties who had been homosexually active for more than five years and had had more than 20 partners, among whom would have been a European. Receptive anogenital intercourse would be an essential part of his sexual activity, which was also likely to include insertive fisting and the use of nitrites. A rash due to a common skin disease was the most likely early symptom, though this was present in less than one third of cases, and extrainguinal lymphadenopathy was the most likely physical finding. Receptive anogenital intercourse was the practice that carried by far the greatest and maybe the only substantial risk of HTLV-III/LAV infection, anal bleeding induced by intercourse having been eliminated as a risk factor by stepwise logistic regression. Indeed, it can be concluded that seropositive men should not under any circumstances practise insertive anogenital intercourse, as the inoculation of HTLV-IIIILAV into the rectum may transmit the agent of an incurable disease 
